09.10.24 -- A Year In, Sanofi's Journey With Plai AI Is Aiding Quality Decisions

To fully optimize their efficiency, modular facilities require integrated modular automation systems. Learn why modular automation is critical.

Conventional QC workflows often involve manual data entry and transfer, which can result in errors. Discover how one partnership is seeking to streamline and unify data management in QC.

Multicomponent filling and sterilizing systems represent unique advantages for vaccine production. See how B/F/S systems can be adapted for vaccine production without incurring any product degradation.

How can pharma companies secure the supply of vital APIs and intermediates and maintain consistent manufacturing costs? These steps minimize supply chain insecurity in a rapidly changing market.

In addition to codifying some best practices, R3 recommends that sponsors adopt an approach to identifying and managing areas of risk to mitigate potential issues and enhance overall success.

To meet immediate vaccine demand, aseptic manufacturing capacity must increase quickly. This means environmental monitoring programs must adapt rapidly as well. Thoughtful planning can help.

Learn how payloads and advanced payload intermediates can expedite drug development and elevate ADC therapies, and explore ADC payloads, payload intermediates, and solubility-enhancing technology.

Spray drying of amorphous dispersions improves solubility and bioavailability that enables supersaturation in the intestine, driving higher absorption rates when compared to crystalline drug forms.

It’s no secret – COVID-19 changed things. Now, as the pharma supply chain settles into a new normal, executives are shifting focus to better identify reliable, resilient, and forward-thinking partners.

Gain insight into how to design and execute an efficient upstream AAV production process, and follow the checklist within to ensure all appropriate factors are considered at each phase of drug development.

When developing a nasal delivery program, a partner with experience in development and manufacturing techniques who can see a program through small-scale clinical to commercial supply is crucial.

Delve into several considerations of risk and knowledge management in the cell and gene therapy environment, providing essential insights for effective product development.

A uniquely modified cyclodextrin is emerging as a versatile and indispensable tool for development. Explore how the right formulation approach can enhance drug delivery and improve patient outcomes.

Explore how a solvent-free alternative for the production of amorphous solid dispersions (ASDs) not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.